Log In
Print this Print this

Chikungunya fever vaccine

  Manage Alerts
Collapse Summary General Information
Company Themis Bioscience GmbH
DescriptionChikungunya virus vaccine developed using Themaxyn technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationChikungunya virus
Indication DetailsVaccinate against Chikungunya virus
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today